Cladosiphon (C.) okamuranus, a brown alga endemic to the Nansei Islands, Japan, has been conventionally ingested as meals. These days, it’s a main aquatic product of the Okinawa Prefecture with an annual manufacturing of round 20,000 tons. The life cycle of C. okamuranus includes the macroscopic sporophyte (algal physique) technology and the microscopic gametophyte technology. The germlings within the latter technology can proliferate when floating in seawater. This floating type has been exploited in methods concerned within the industrial manufacturing of C. okamuranus seedlings.
Brown algae include fucoxanthin, a carbonyl carotenoid recognized to have anticancer, anti-obesity, and antidiabetic impact along with the anti-oxidation impact. We discovered that the fucoxanthin content material of cultivated floating type of C. okamuranus discoid germlings turns into as much as 50 occasions that of the mature alga. For the reason that discoid germlings repeatedly develop like microorganisms, though they’re giant algae, they’re utilized to provide fucoxanthin. We optimize the tradition situations by altering the temperature, gentle depth, photoperiod, gentle wavelength, and nutrient salt situations for optimum fucoxanthin productiveness.
The cultivation has been profitable to industrial plant scale, culminating in using 1 ton of cultivating medium.In brown algal cells, fucoxanthin is primarily discovered sure to the photosynthetic pigment-protein complexes referred to as fucoxanthin-chlorophyll protein (FCP). Consequently cultivated floating type of C. okamuranus additionally exhibits excessive content material of FCP. Isolation and characterization of pigments sure to the FCP have been decided exactly, and ultrafast spectroscopies have been utilized to elucidate the photosynthetic operate of fucoxanthin sure to the pigment-protein complexes.
This cultivation methodology has additionally been utilized to the opposite edible brown algae. We discovered that the optimum cultivation situations in addition to the yields of fucoxanthin and FCP extremely rely on the species.The floating type cultivation was additionally utilized to a large-sized edible inexperienced alga, Codium intricatum, which is uniquely producing a carbonyl carotenoid, siphonaxanthin. This has a number of anti-disease results and can be a primal photosynthetic pigment which is discovered sure to photosynthetic antenna complicated often referred to as siphonaxanthin-chlorophyll protein (SCP). We’re engaged on the development of productiveness, scale-up of manufacturing, and improvement of cultivation expertise of latest macro algae.
Recombinant Humanp21 Recombinant Protein |
92-035 |
TWEAK, recombinant / TNFSF12, recombinant (Human) |
054-85 |
TAGLN Recombinant Protein (Rat) (Recombinant- Tag) |
RP232205 |
TAGLN2 Recombinant Protein (Rat) (Recombinant Tag) |
RP232208 |
TAGLN3 Recombinant Protein (Rat) (Recombinant Tag) |
RP232211 |
Pilot-scale cultivation of water-net in secondary effluent utilizing an open pond raceway for nutrient elimination and bioethanol manufacturing
Though microalgae are seen as a possible different supply of power and different supplies at the moment sourced from petroleum, points nonetheless stay with industrialization due to difficulties in creating commercially operational microalgal manufacturing programs. We arrange a pilot-scale research that concerned the simultaneous reuse of wastewater and manufacturing of algae underneath completely different gentle and harvesting situations. We cultivated Hydrodictyon reticulatum (H. reticulatum), a sort of water-net algae, utilizing secondary effluent from a wastewater remedy plant in a raceway open pond mixed with an underwater gentle gadget.
Recombinant Humanp21 Recombinant Protein |
ProSci |
TWEAK, recombinant / TNFSF12, recombinant (Human) |
PHOENIX PEPTIDE |
TAGLN Recombinant Protein (Rat) (Recombinant- Tag) |
ABM |
TAGLN2 Recombinant Protein (Rat) (Recombinant Tag) |
ABM |
TAGLN3 Recombinant Protein (Rat) (Recombinant Tag) |
ABM |
Experimental outcomes confirmed that the underwater gentle gadget maintained some stage of underwater gentle all year long. Photoinhibition of algal progress solely occurred when the daylight exceeded 1270 μmol m-2 s-1. Through the non-harvest course of, the utmost algal focus was 1700 mg L-1 at 20 days after the experiment started, the utmost particular progress charge was 0.18 d-1 and the utmost productiveness was 21.Three g m-2 d-1. Conversely, periodic harvesting decreased the focus of vitamins within the effluent extra as the times of cultivation elevated, however the productiveness of algae additionally decreased to 11.7 g m-2 d-1. The utmost yield of bioethanol utilizing three sorts of fermentation strains was 93.5% and, thus, the industrial worth of H. reticulatum as a uncooked materials for power manufacturing was glorious.
Insights into the physiology of Chlorella vulgaris cultivated in candy sorghum bagasse hydrolysate for sustainable algal biomass and lipid manufacturing
Supplementing cultivation media with exogenous carbon sources enhances biomass and lipid manufacturing in microalgae. Utilization of renewable natural carbon from agricultural residues can doubtlessly scale back the price of algae cultivation, whereas enhancing sustainability. Within the current investigation a medium was developed from candy sorghum bagasse for cultivation of Chlorella underneath mixotrophic situations. Utilizing response floor methodology, the optimum values of essential course of parameters have been decided, particularly inoculum cell density (O.D.750) of 0.786, SSB hydrolysate content material of the medium 25% v/v, and 0 medium salinity, to attain most lipid productiveness of 120 mg/L/d.
Enhanced biomass (3.44 g/L) and lipid content material (40% of dry cell weight) have been noticed when the alga was cultivated in SSB hydrolysate underneath mixotrophic situations in comparison with heterotrophic and photoautotrophic situations. A time course investigation revealed distinct physiological responses when it comes to mobile progress and biochemical composition of C. vulgaris cultivated within the varied trophic modes. The decided carbohydrate and lipid profiles point out that sugar addition to the cultivation medium boosts impartial lipid synthesis in comparison with structural lipids, suggesting that carbon flux is channeled in direction of triacylglycerol synthesis within the cells.
Sodium alginate |
PCT1317-100G |
EWC Diagnostics |
1 unit |
EUR 6.93 |
Description: Sodium alginate |
Sodium alginate |
PCT1317-500G |
EWC Diagnostics |
1 unit |
EUR 17.46 |
Description: Sodium alginate |
Sodium alginate |
MB114-100G |
EWC Diagnostics |
1 unit |
EUR 18.5 |
Description: Sodium alginate |
Sodium alginate |
MB114-500G |
EWC Diagnostics |
1 unit |
EUR 83.07 |
Description: Sodium alginate |
Sodium alginate |
GRM7494-500G |
EWC Diagnostics |
1 unit |
EUR 15.95 |
Description: Sodium alginate |
Sodium alginate |
GRM7494-5KG |
EWC Diagnostics |
1 unit |
EUR 142.56 |
Description: Sodium alginate |
Alginate Antibody |
abx440080-100ug |
Abbexa |
100 ug |
EUR 727.2 |
|
Alginate Antibody |
abx440081-100ug |
Abbexa |
100 ug |
EUR 727.2 |
|
Alginate Antibody |
abx440361-100ug |
Abbexa |
100 ug |
EUR 727.2 |
|
Alginate Antibody |
abx440362-100ug |
Abbexa |
100 ug |
EUR 727.2 |
|
Alginate Antibody |
abx440642-100ug |
Abbexa |
100 ug |
EUR 727.2 |
|
Alginate Antibody |
abx440643-100ug |
Abbexa |
100 ug |
EUR 727.2 |
|
Alginate Antibody |
abx440923-100ug |
Abbexa |
100 ug |
EUR 727.2 |
|
Alginate Antibody |
abx440924-100ug |
Abbexa |
100 ug |
EUR 727.2 |
|
Alginate Antibody |
abx441204-100ug |
Abbexa |
100 ug |
EUR 727.2 |
|
Alginate Antibody |
abx441205-100ug |
Abbexa |
100 ug |
EUR 727.2 |
|
Alginate Antibody |
abx441485-100ug |
Abbexa |
100 ug |
EUR 727.2 |
|
Alginate Antibody |
abx441486-100ug |
Abbexa |
100 ug |
EUR 727.2 |
|
Alginate Antibody |
abx441766-100ug |
Abbexa |
100 ug |
EUR 727.2 |
|
Alginate Antibody |
abx441767-100ug |
Abbexa |
100 ug |
EUR 727.2 |
|
Alginate Antibody |
abx442047-100ug |
Abbexa |
100 ug |
EUR 727.2 |
|
Alginate Antibody |
abx442048-100ug |
Abbexa |
100 ug |
EUR 727.2 |
|
Alginate Antibody |
abx442328-100ug |
Abbexa |
100 ug |
EUR 710.4 |
|
Alginate Antibody |
abx442329-100ug |
Abbexa |
100 ug |
EUR 710.4 |
|
Alginate Antibody |
abx442609-100ug |
Abbexa |
100 ug |
EUR 727.2 |
|
Alginate Antibody |
abx442610-100ug |
Abbexa |
100 ug |
EUR 727.2 |
|
Alginate Antibody |
abx442889-100ug |
Abbexa |
100 ug |
EUR 727.2 |
|
Alginate Antibody |
abx442890-100ug |
Abbexa |
100 ug |
EUR 727.2 |
|
Alginate Antibody |
abx443169-100ug |
Abbexa |
100 ug |
EUR 710.4 |
|
Alginate Antibody |
abx443170-100ug |
Abbexa |
100 ug |
EUR 710.4 |
|
Alginate Antibody |
abx443450-100ug |
Abbexa |
100 ug |
EUR 710.4 |
|
Alginate Antibody |
abx443451-100ug |
Abbexa |
100 ug |
EUR 710.4 |
|
Alginate Antibody |
abx443731-100ug |
Abbexa |
100 ug |
EUR 727.2 |
|
Alginate Antibody |
abx443732-100ug |
Abbexa |
100 ug |
EUR 727.2 |
|
Alginate Antibody |
abx444930-100ug |
Abbexa |
100 ug |
EUR 661.2 |
|
Alginate Antibody |
abx444931-100ug |
Abbexa |
100 ug |
EUR 661.2 |
|
Alginate Antibody |
abx444012-100ug |
Abbexa |
100 ug |
EUR 727.2 |
|
Alginate Antibody |
abx444013-100ug |
Abbexa |
100 ug |
EUR 727.2 |
|
Alginate Antibody |
abx444293-100ug |
Abbexa |
100 ug |
EUR 727.2 |
|
Alginate Antibody |
abx444294-100ug |
Abbexa |
100 ug |
EUR 727.2 |
|
Alginate Antibody |
abx444574-100ug |
Abbexa |
100 ug |
EUR 727.2 |
|
Alginate Antibody |
abx444575-100ug |
Abbexa |
100 ug |
EUR 727.2 |
|
Alginate Antibody |
abx444930-200l |
Abbexa |
200 µl |
EUR 575 |
Alginate Antibody |
abx444931-200l |
Abbexa |
200 µl |
EUR 575 |
Alginate Antibody |
MBS800227-01mg |
MyBiosource |
0.1mg |
EUR 460 |
Alginate Antibody |
MBS800227-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1805 |
Alginate Antibody |
MBS800396-01mg |
MyBiosource |
0.1mg |
EUR 460 |
Alginate Antibody |
MBS800396-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1805 |
Alginate lyase (algL) |
1-CSB-EP524422DPX |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Alginate lyase(algL) expressed in E.coli |
Alginate Antibody (PE) |
abx444293-100g |
Abbexa |
100 µg |
EUR 637.5 |
Alginate Antibody (PE) |
abx444294-100g |
Abbexa |
100 µg |
EUR 637.5 |
Alginate Antibody (APC) |
abx442609-100g |
Abbexa |
100 µg |
EUR 637.5 |
Alginate Antibody (APC) |
abx442610-100g |
Abbexa |
100 µg |
EUR 637.5 |
Alginate Antibody (HRP) |
abx443450-100g |
Abbexa |
100 µg |
EUR 625 |
Alginate Antibody (HRP) |
abx443451-100g |
Abbexa |
100 µg |
EUR 625 |
Alginate Antibody: HRP |
MBS801465-01mg |
MyBiosource |
0.1mg |
EUR 500 |
Alginate Antibody: HRP |
MBS801465-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1985 |
Alginate Antibody: RPE |
MBS801502-01mg |
MyBiosource |
0.1mg |
EUR 510 |
Alginate Antibody: RPE |
MBS801502-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2030 |
Alginate Antibody: HRP |
MBS804276-01mg |
MyBiosource |
0.1mg |
EUR 500 |
Alginate Antibody: HRP |
MBS804276-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1985 |
Alginate Antibody: RPE |
MBS804647-01mg |
MyBiosource |
0.1mg |
EUR 510 |
Alginate Antibody: RPE |
MBS804647-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2030 |
Recombinant Pseudomonas putida Alginate biosynthesis protein AlgA (algA) |
MBS1462702-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1350 |
Recombinant Pseudomonas putida Alginate biosynthesis protein AlgA (algA) |
MBS1462702-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 1050 |
Recombinant Pseudomonas putida Alginate biosynthesis protein AlgA (algA) |
MBS1462702-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1120 |
Recombinant Pseudomonas putida Alginate biosynthesis protein AlgA (algA) |
MBS1462702-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1225 |
Recombinant Pseudomonas putida Alginate biosynthesis protein AlgA (algA) |
MBS1462702-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1305 |
Alginate Antibody (FITC) |
abx443169-100g |
Abbexa |
100 µg |
EUR 625 |
Alginate Antibody (FITC) |
abx443170-100g |
Abbexa |
100 µg |
EUR 625 |
Alginate Antibody: FITC |
MBS800754-01mg |
MyBiosource |
0.1mg |
EUR 505 |
Alginate Antibody: FITC |
MBS800754-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2005 |
Alginate Antibody: FITC |
MBS803658-01mg |
MyBiosource |
0.1mg |
EUR 505 |
Alginate Antibody: FITC |
MBS803658-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2005 |
Alginate Antibody (PerCP) |
abx444012-100g |
Abbexa |
100 µg |
EUR 637.5 |
Alginate Antibody (PerCP) |
abx444013-100g |
Abbexa |
100 µg |
EUR 637.5 |
Alginate Antibody: PerCP |
MBS800851-01mg |
MyBiosource |
0.1mg |
EUR 510 |
Alginate Antibody: PerCP |
MBS800851-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2040 |
Alginate Antibody: PerCP |
MBS802458-01mg |
MyBiosource |
0.1mg |
EUR 510 |
Alginate Antibody: PerCP |
MBS802458-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2040 |
Alginate Antibody (Biotin) |
abx442889-100g |
Abbexa |
100 µg |
EUR 625 |
Alginate Antibody (Biotin) |
abx442890-100g |
Abbexa |
100 µg |
EUR 625 |
Alginate Antibody: Biotin |
MBS800529-01mg |
MyBiosource |
0.1mg |
EUR 505 |
Alginate Antibody: Biotin |
MBS800529-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2025 |
Alginate Antibody: Biotin |
MBS802284-01mg |
MyBiosource |
0.1mg |
EUR 505 |
Alginate Antibody: Biotin |
MBS802284-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2025 |
Recombinant Pseudomonas aeruginosa Alginate biosynthesis protein AlgA (algA) |
MBS1016101-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1345 |
Recombinant Pseudomonas aeruginosa Alginate biosynthesis protein AlgA (algA) |
MBS1016101-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 1045 |
Recombinant Pseudomonas aeruginosa Alginate biosynthesis protein AlgA (algA) |
MBS1016101-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1140 |
Recombinant Pseudomonas aeruginosa Alginate biosynthesis protein AlgA (algA) |
MBS1016101-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1220 |
Recombinant Pseudomonas aeruginosa Alginate biosynthesis protein AlgA (algA) |
MBS1016101-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1300 |
Alginate lyase (algL) Antibody |
abx345870-100g |
Abbexa |
100 µg |
Ask for price |
Alginate lyase (algL) Antibody |
abx345870-20g |
Abbexa |
20 µg |
EUR 250 |
Alginate lyase (algL) Antibody |
abx345870-50g |
Abbexa |
50 µg |
EUR 350 |
Alginate Antibody (ATTO594) |
abx440923-100g |
Abbexa |
100 µg |
EUR 637.5 |
Alginate Antibody (ATTO594) |
abx440924-100g |
Abbexa |
100 µg |
EUR 637.5 |
Alginate Antibody (ATTO390) |
abx440080-100g |
Abbexa |
100 µg |
EUR 637.5 |
Alginate Antibody (ATTO390) |
abx440081-100g |
Abbexa |
100 µg |
EUR 637.5 |
Alginate Antibody (ATTO488) |
abx440361-200g |
Abbexa |
200 µg |
Ask for price |
Alginate Antibody (ATTO488) |
abx440361-50g |
Abbexa |
50 µg |
EUR 637.5 |
Alginate Antibody (ATTO488) |
abx440362-200g |
Abbexa |
200 µg |
Ask for price |
Alginate Antibody (ATTO488) |
abx440362-50g |
Abbexa |
50 µg |
EUR 637.5 |
Recombinant Pseudomonas fluorescens Alginate biosynthesis protein AlgA (algA) |
MBS1002714-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1350 |
Recombinant Pseudomonas fluorescens Alginate biosynthesis protein AlgA (algA) |
MBS1002714-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 1045 |
Recombinant Pseudomonas fluorescens Alginate biosynthesis protein AlgA (algA) |
MBS1002714-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1120 |
Recombinant Pseudomonas fluorescens Alginate biosynthesis protein AlgA (algA) |
MBS1002714-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1220 |
Recombinant Pseudomonas fluorescens Alginate biosynthesis protein AlgA (algA) |
MBS1002714-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1300 |
Alginate Antibody: ATTO 390 |
MBS800779-01mg |
MyBiosource |
0.1mg |
EUR 515 |
Alginate Antibody: ATTO 390 |
MBS800779-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2050 |
Alginate Antibody: ATTO 390 |
MBS801033-01mg |
MyBiosource |
0.1mg |
EUR 515 |
Alginate Antibody: ATTO 390 |
MBS801033-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2050 |
Alginate Antibody: ATTO 488 |
MBS802116-01mg |
MyBiosource |
0.1mg |
EUR 510 |
Alginate Antibody: ATTO 488 |
MBS802116-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2045 |
Alginate Antibody: ATTO 488 |
MBS802586-01mg |
MyBiosource |
0.1mg |
EUR 510 |
Alginate Antibody: ATTO 488 |
MBS802586-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2045 |
Moreover, the fatty acid profile of lipids extracted from mixotrophically grown cultures contained extra saturated and monosaturated fatty acids, that are appropriate for biofuel manufacturing. Scale-up research in a photobioreactor utilizing SSB hydrolysate achieved a biomass focus of two.83 g/L consisting of 34% lipids and 26% carbohydrates. These outcomes confirmed that SSB hydrolysate is a promising feedstock for mixotrophic cultivation of Chlorella and synthesis of algal bioproducts and biofuels.